Jagsonpal Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /66
Jagsonpal Pharmaceuticals has a total shareholder equity of ₹2.0B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹2.6B and ₹611.0M respectively. Jagsonpal Pharmaceuticals's EBIT is ₹226.5M making its interest coverage ratio -2.9. It has cash and short-term investments of ₹778.5M.
主要情報
0%
負債資本比率
₹0
負債
| インタレスト・カバレッジ・レシオ | -2.9x |
| 現金 | ₹778.45m |
| エクイティ | ₹1.97b |
| 負債合計 | ₹610.95m |
| 総資産 | ₹2.58b |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: 507789's short term assets (₹1.4B) exceed its short term liabilities (₹469.9M).
長期負債: 507789's short term assets (₹1.4B) exceed its long term liabilities (₹141.0M).
デット・ツー・エクイティの歴史と分析
負債レベル: 507789 is debt free.
負債の削減: 507789 has no debt compared to 5 years ago when its debt to equity ratio was 4.1%.
債務返済能力: 507789 has no debt, therefore it does not need to be covered by operating cash flow.
インタレストカバレッジ: 507789 has no debt, therefore coverage of interest payments is not a concern.